374 related articles for article (PubMed ID: 27067962)
1. Primary prophylaxis of VTE in cancer outpatients.
Imberti D; Benedetti R
Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
[TBL] [Abstract][Full Text] [Related]
2. Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis.
Lustig DB; Rodriguez R; Wells PS
Thromb Res; 2015 Dec; 136(6):1099-102. PubMed ID: 26260645
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of venous thromboembolism in cancer patients.
Frere C; Doucet L; Farge D
Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study.
Panizo E; Alfonso A; García-Mouriz A; López-Picazo JM; Gil-Bazo I; Hermida J; Páramo JA; Lecumberri R
Thromb Res; 2015 Dec; 136(6):1145-8. PubMed ID: 26475407
[TBL] [Abstract][Full Text] [Related]
6. Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic.
Holmes CE; Ades S; Gilchrist S; Douce D; Libby K; Rogala B; Parenteau E; Cushman M; Holm AK
JCO Oncol Pract; 2020 Sep; 16(9):e868-e874. PubMed ID: 32267798
[TBL] [Abstract][Full Text] [Related]
7. New strategies of VTE prevention in cancer patients.
Verso M; Agnelli G
Thromb Res; 2014 May; 133 Suppl 2():S128-32. PubMed ID: 24862133
[TBL] [Abstract][Full Text] [Related]
8. Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.
Streiff MB
Clin Adv Hematol Oncol; 2013 Jun; 11(6):349-57. PubMed ID: 24472803
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
10. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
[TBL] [Abstract][Full Text] [Related]
12. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
Khorana AA; Francis CW; Kuderer NM; Carrier M; Ortel TL; Wun T; Rubens D; Hobbs S; Iyer R; Peterson D; Baran A; Kaproth-Joslin K; Lyman GH
Thromb Res; 2017 Mar; 151():89-95. PubMed ID: 28139259
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prevention in cancer outpatients.
Khorana AA
J Natl Compr Canc Netw; 2013 Nov; 11(11):1431-8. PubMed ID: 24225974
[TBL] [Abstract][Full Text] [Related]
14. Thromboprophylaxis in non-surgical cancer patients.
Cohen AT; Gurwith MM; Dobromirski M
Thromb Res; 2012 Apr; 129 Suppl 1():S137-45. PubMed ID: 22682125
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism and cancer.
MacLellan DG; Richardson A; Stoodley MA
ANZ J Surg; 2012 May; 82(5):294-8. PubMed ID: 22507393
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Pelletier R
J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
[TBL] [Abstract][Full Text] [Related]
17. Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.
Roopkumar J; Khorana AA
Cancer Treat Res; 2019; 179():55-68. PubMed ID: 31317480
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
[TBL] [Abstract][Full Text] [Related]
19. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of primary thromboprophylaxis in cancer patients.
García Escobar I; Antonio Rebollo M; García Adrián S; Rodríguez-Garzotto A; Muñoz Martín A;
Clin Transl Oncol; 2017 Jan; 19(1):1-11. PubMed ID: 27147252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
